Skip to main content
. Author manuscript; available in PMC: 2011 Mar 27.
Published in final edited form as: AIDS. 2010 Mar 27;24(6):857–865. doi: 10.1097/QAD.0b013e328334bddb

Table 4.

Multivariate model of predictors of antiretroviral therapy reinitiation in the SMART drug conservation arm

Univariate Multivariate
Hazard ratio P-value Hazard ratio P-value
Non-HBV/HCV 1.00 1.00
HBV 1.95 (1.45–2.63) <0.0001 1.71 (1.27 – 2.31) 0.0005
HCV 1.01 (0.87–1.18) 0.87 1.04 (0.88 – 1.22) 0.66
Prior AIDS 2.17 (1.91–2.45) <0.0001 1.41 (1.24 – 1.61) <0.0001
Nadir CD4 count (/100
cells lower)
1.67 (1.60–1.75) <0.0001 1.50 (1.42 – 1.58) <0.0001
Baseline CD4 count (/100
cells lower)
1.20 (1.16–1.23) <0.0001 1.14 (1.11 – 1.18) <0.0001
Baseline HIV RNA ≤400
copies/ml
1.18 (1.04–1.34) 0.011 1.19 (1.04 – 1.37) 0.012
Highest HIV RNA (Log10) 1.34 (1.25–1.44) <0.0001 1.19 (1.11 – 1.28) <0.0001
Female 0.97 (0.84–1.11) 0.61 1.01 (0.88 – 1.16) 0.89
Age (/10 years) 1.15 (1.08–1.22) <0.0001 1.13 (1.06 – 1.20) 0.0003

Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus; AIDS, acquired immune deficiency syndrome.